Myelofibrosis Prognosis

Prognostic criteria

Determining prognosis can be challenging because myelofibrosis has a very heterogeneous presentation. As the clinical understanding of myelofibrosis has evolved, a variety of prognostic systems have been developed.1

The International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) has developed the International Prognostic Scoring System (IPSS) and the Dynamic International Prognostic Scoring System (DIPSS), used to determine a patient's risk group at diagnosis and over time, respectively.1,2

The final score may be related to a patient's prognosis.1,2


Prognostic Scoring Systems


  1. Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2009;113:2895-2901.
  2. Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 2010;115:1703-1708.
Join Today

Become a member of Gain access to member-only benefits.

MOA of Jakafi

Learn more about JAK signaling and the mechanism of action (MOA) of Jakafi.

Symptoms Efficacy

Superior improvements in core symptoms of myelofibrosis with Jakafi.


Select and order materials and resources that can assist you and your patients.